Detalhe da pesquisa
1.
A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry.
Proc Natl Acad Sci U S A;
118(50)2021 12 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34876524
2.
A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike Protein.
Int J Mol Sci;
25(9)2024 Apr 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38731860
3.
SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses.
J Virol;
95(15): e0020321, 2021 07 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33963055
4.
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
J Virol;
93(3)2019 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30429340
5.
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
J Virol;
93(3)2019 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30429343
6.
Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.
J Virol;
92(15)2018 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29769344
7.
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
BMC Immunol;
18(1): 14, 2017 03 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28270111
8.
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
J Virol;
90(8): 4133-4149, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26865719
9.
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
J Virol;
89(2): 970-88, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25355891
10.
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.
J Virol;
89(16): 8525-39, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26041302
11.
Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC".
J Virol;
93(21)2019 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31615930
12.
Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages.
Front Immunol;
15: 1338492, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38380318
13.
Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome-Positive C3 Cancers in Mice.
Cancer Immunol Res;
11(2): 261-275, 2023 02 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36534088
14.
Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors' PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion Antigen.
Cancers (Basel);
15(24)2023 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38136407
15.
Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein.
Front Immunol;
14: 1270908, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38045703
16.
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.
Front Immunol;
14: 1118523, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36911730
17.
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses.
Nat Biomed Eng;
2023 Sep 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37749309
18.
Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants.
Vaccines (Basel);
10(2)2022 Feb 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35214782
19.
Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design.
Vaccines (Basel);
10(9)2022 Sep 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36146598
20.
Antibodies against viral nucleo-, phospho-, and X protein contribute to serological diagnosis of fatal Borna disease virus 1 infections.
Cell Rep Med;
3(1): 100499, 2022 01 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35106511